8 completed, 6 active not recruiting, 1 terminated, 1 withdrawn. 7 Not applicable, 5 Phase 2, 3 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 7 | Active not recruiting 6, Completed 1 |
| Phase 2 | 5 | Completed 4, Withdrawn 1 |
| Phase 1 | 3 | Completed 2, Terminated 1 |
| Phase 3 | 1 | Completed 1 |
Follow Prognostic Stage 0 Breast Cancer AJCC v8: new trials by email Literature Review of Prognostic Stage 0 Breast Cancer AJCC v8 trials Research Report on Prognostic Stage 0 Breast Cancer AJCC v8
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Volumetric Specimen Imager Device for the Intraoperative Imaging of Patients With Breast Carcinoma and Breast Ductal Carcinoma In Situ, The VIVID Study Intraoperative Imaging, Lumpectomy - Anatomic Stage 0 Breast Cancer AJCC v8, Bilateral Breast Carcinoma | Phase 2 | Completed | Northwestern University | 113 | 2022-11-28 | 2026-08-19 |
| Standard Verbal Counseling With or Without a Pictorial Educational Tool for the Reduction of Psychological Morbidity in Patients With Stage 0-IIIA Breast Cancer Receiving Radiation Therapy, COPE Study Counseling, Educational Intervention, Questionnaire - Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8 | Not applicable | Active not recruiting | OHSU Knight Cancer Institute | 62 | 2022-03-18 | 2026-09-15 |
| An Episodic Future Thinking Intervention to Promote Weight Loss in Breast Cancer Survivors Behavioral Intervention, Quality-of-Life Assessment, Questionnaire Administration - Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8 | Not applicable | Completed | Ohio State University Comprehensive Cancer Center | 50 | 2021-11-01 | 2025-02-07 |
| Safely Stopping Pre-medications in Patients With Breast Cancer Who Are Receiving Paclitaxel Cimetidine, Dexamethasone, Diphenhydramine - Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8 | Phase 2 / Phase 3 | Completed | Ohio State University Comprehensive Cancer Center | 130 | 2021-10-07 | 2025-08-20 |
| Oxaloacetate for the Improvement of Cognitive Complaints in Stage 0-IIIA Breast Cancer Survivors Anhydrous Enol-oxaloacetate, Questionnaire Administration - Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8 | Phase 2 | Completed | Jonsson Comprehensive Cancer Center | 18 | 2021-09-29 | 2025-07-15 |
| Culturally Based Brief Expressive Writing Intervention for the Improvement of Health in Chinese Immigrant Stage 0-III Breast Cancer Survivors, Writing to Heal Study Behavioral, Psychological or Informational Intervention, Best Practice, Quality-of-Life Assessment - Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8 | Not applicable | Active not recruiting | M.D. Anderson Cancer Center | 256 | 2021-07-23 | 2026-08-21 |
| Web-Based Symptom Monitoring and Self-Management Portal (YES) for Adolescent and Young Adult Breast Cancer Survivors Best Practice, Internet-Based Intervention, Survey Administration - Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8 | Not applicable | Active not recruiting | Ohio State University Comprehensive Cancer Center | 400 | 2021-06-28 | 2026-02-19 |
| Radiation Therapy Boost Before Surgery for the Treatment of Non-metastatic Breast Cancer Quality-of-Life Assessment, Questionnaire Administration, Radiation Boost - Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8 | Not applicable | Active not recruiting | Rutgers, The State University of New Jersey | 103 | 2021-05-18 | 2026-01-22 |
| Multiscale Omics for the Development of a Cohort Database and Study Platform in Breast Cancer Survivors Biospecimen Collection, Quality-of-Life Assessment, Questionnaire Administration - Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8 | Completed | Mayo Clinic | 105 | 2021-04-01 | 2025-12-30 | |
| Improving Patient-Centered Communication in Breast Cancer Through Patient and Provider Interventions Decision Aid iCanDecide - ESE website, Decision Aid iCanDecide - S website, Therapeutic Conventional Surgery - Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8 | Not applicable | Active not recruiting | Alliance for Clinical Trials in Oncology | 543 | 2021-02-16 | 2025-04-02 |
| Platelet Rich Plasma for the Treatment of Genitourinary Syndrome of Menopause in Patients With Stage 0-III Breast Cancer Quality-of-Life Assessment, Questionnaire Administration, Therapeutic Autologous Platelet-rich Plasma - Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8 | Phase 1 | Completed | Mayo Clinic | 20 | 2020-09-23 | 2024-04-03 |
| Lifestyle Program (Scalable Nutrition and Physical Activity) for the Improvement of Nutrition and Physical Activity in Stage 0-III Breast Cancer Survivors One Diet and Physical Activity Session, Electronic (e) Health (eHealth) Communication Intervention, Twelve Diet and Physical Activity Group Sessions - Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8 | Phase 2 | Completed | Fred Hutchinson Cancer Center | 90 | 2020-02-21 | 2021-11-04 |
| Chemokine Modulation Therapy and Standard Chemotherapy Before Surgery for the Treatment of Early Stage Triple Negative Breast Cancer Celecoxib, Cyclophosphamide, Doxorubicin - Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8 | Phase 1 | Completed | Roswell Park Cancer Institute | 9 | 2019-12-06 | 2023-09-11 |
| Ipilimumab, Nivolumab, and Talimogene Laherparepvec Before Surgery in Treating Participants With Localized, Triple-Negative or Estrogen Receptor Positive, HER2 Negative Breast Cancer-deleted Ipilimumab, Nivolumab, Talimogene Laherparepvec - Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8 | Phase 1 | Terminated | Jonsson Comprehensive Cancer Center | 6 | 2019-07-10 | 2023-08-15 |
| Carbon Dioxide Fractional Laser in Treating Participants With Stage 0-III Hormone Receptor-Positive Breast Cancer With Vulvovaginal Atrophy Carbon Dioxide Fractional Laser, Questionnaire Administration - Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8 | Phase 2 | Withdrawn | Mayo Clinic | 2018-09-10 | 2023-01-06 | |
| Hypnosedation in Relaxing Patients Undergoing Breast Cancer Surgery Hypnosedation, Questionnaire Administration, Verbal Support - Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8 | Not applicable | Active not recruiting | M.D. Anderson Cancer Center | 50 | 2017-03-07 | 2026-09-14 |
Breast Carcinoma In Situ (16) · Breast Neoplasms (4) · Carcinoma, Intraductal, Noninfiltrating (2) · Triple Negative Breast Neoplasms (2) · Dyspareunia (1) · Motor Activity (1)
Breast Diseases (16) · Carcinoma (16) · Carcinoma in Situ (16) · Neoplasms (16) · Neoplasms by Histologic Type (16) · Neoplasms by Site (16) · Neoplasms, Glandular and Epithelial (16) · Skin Diseases (16) · Skin and Connective Tissue Diseases (16) · Breast Neoplasms (12) · Adenocarcinoma (2) · Neoplasms, Ductal, Lobular, and Medullary (2) · Behavior (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1)
Practice Guidelines as Topic (3) · Behavior Therapy (2) · Paclitaxel (2) · Standard of Care (2) · Taxes (2) · CTLA-4 Antigen (1) · Calcium Dobesilate (1) · Celecoxib (1) · Cimetidine (1) · Counseling (1) · Cyclophosphamide (1) · Dexamethasone (1) · Diphenhydramine (1) · Doxorubicin (1) · Early Intervention, Educational (1)
Mayo Clinic (3) · Ohio State University Comprehensive Cancer Center (3) · Jonsson Comprehensive Cancer Center (2) · M.D. Anderson Cancer Center (2) · Alliance for Clinical Trials in Oncology (1) · Fred Hutchinson Cancer Center (1) · Northwestern University (1) · OHSU Knight Cancer Institute (1) · Roswell Park Cancer Institute (1) · Rutgers, The State University of New Jersey (1)
United States (15)
Anita H. Chen, M.D. (1) · Brent A. Bauer, M.D. (1) · Bruce G Haffty (1) · Carl Post (1) · Heather Greenlee (1) · John A Glaspy (1) · Lorenzo Cohen (1) · Michael J Berger, Pharm.D. (1) · Michelle Naughton, PhD (1) · Nancy E Davidson (1) · Patricia A Ganz (1) · Qian Lu (1) · Sagar D Sardesai, MBBS MPH (1) · Sarah T. Hawley, PhD, MPH (1) · Saranya Chumsri (1)
PMID 35788100, PMID 36336249, PMID 36609349, PMID 37621406, PMID 39325778, PMID 40966714, PMID 42804742
P30CA016672 (1), P30CA060553 (1), P30CA072720 (1), R01CA237046 (1), R44CA206801 (1), U01CA246648 (1), UG1CA189823 (1), UL1TR001412 (1)